Huihan Technology
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Huihan Technology - overview
Established
2005
Location
Suzhou, Jiangsu, China
Primary Industry
Healthcare
About
Founded in 2005 and based in Suzhou, China, Huihan Technology is a developer of antimicrobial drugs and healthcare products, primarily engaged in the research, development, production, and sales of antimicrobial drugs, low-value consumables, and healthcare products. In August 2025, Huihan Technology closed a Series B funding from new investor Jiangsu Runhuai Private Equity Fund Management Co. , Ltd. The company provides bio-surgical technologies such as bio-3D printed surgical aids, trauma care systems, wound treatment solutions, and surgical applications developed in collaboration with leading research teams.
The company generates revenue through direct sales of its bio-3D printed surgical aids and trauma care systems to healthcare providers, B2B partnerships with medical institutions, and service contracts for product support and maintenance. The funding raised in August 2025 will focus on capacity expansion and automation upgrades in the biomedical materials segment, further strengthening its technological advantages in hemostasis, sealing, and tissue repair.
Current Investors
Jiangsu Runhuai Private Equity Fund Management Co., Ltd.
Primary Industry
Healthcare
Sub Industries
Biotechnology, Healthcare, Medical Devices & Equipment, Pharmaceutical Research & Development, Pharmaceuticals
Website
www.hvha.cn
Verticals
Manufacturing
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.